MEGAN COLEMAN: Open Payments
NPI 1326671157 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,203 in 103 payments from 22 companies in 2025. Trend: 2023 $866 · 2024 $2,081 · 2025 $3,203
Food & beverage: $2,577Travel & lodging: $626
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 11 | $1,087 |
| AstraZeneca Pharmaceuticals LP | 9 | $271 |
| E.R. Squibb & Sons, L.L.C. | 9 | $206 |
| Novartis Pharmaceuticals Corporation | 9 | $194 |
| PFIZER INC. | 8 | $189 |
| Impulse Dynamics (USA) Inc. | 5 | $187 |
| Merck Sharp & Dohme LLC | 8 | $160 |
| Amgen Inc. | 9 | $146 |
| Novo Nordisk Inc | 8 | $139 |
| Esperion Therapeutics, Inc. | 6 | $113 |
Products named: Barostim Neo System, ELIQUIS, Optimizer, LEQVIO, Repatha, Wegovy, VERQUVO, NEXLETOL.
Industry payments across SC — which companies pay providers there.
